Jane Street’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-203,986
Closed -$516K 10442
2023
Q4
$516K Buy
203,986
+187,996
+1,176% +$438K ﹤0.01% 6706
2023
Q3
$38.2K Sell
15,990
-270
-2% -$598 ﹤0.01% 8210
2023
Q2
$37.6K Sell
16,260
-16,193
-50% -$45.7K ﹤0.01% 8272
2023
Q1
$82.8K Buy
32,453
+16,878
+108% +$48.4K ﹤0.01% 8305
2022
Q4
$39.1K Sell
15,575
-21,258
-58% -$59.3K ﹤0.01% 8441
2022
Q3
$107K Buy
+36,833
New +$155K ﹤0.01% 8615
2022
Q2
Sell
-200,161
Closed -$1.6M 11260
2022
Q1
$1.6M Buy
+200,161
New +$1.77M ﹤0.01% 5165
2021
Q4
Sell
-43,775
Closed -$542K 11005
2021
Q3
$542K Buy
+43,775
New +$494K ﹤0.01% 7132

Jane Street's SLGC Position: Q1 2024 in Review

Jane Street sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 203,986 shares — an estimated $516K sold.

Jane Street first reported a position in SLGC in Q3 2021 and held it in 8 quarters. The position peaked at $1.6M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Jane Street reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 203,986 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $516K.
  • Jane Street first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Jane Street's SomaLogic, Inc. Class A Common Stock position peaked at $1.6M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.